Estrella ImmunopharmaESLA
13F holders, Q1 2025 (March 31)11holders
1new positions
1sold out
1famous investor
$0.93avg. 13F price*
At the end of Q1 2025, 11 institutions reported holding Estrella Immunopharma Inc. (ESLA) in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($257K), Geode Capital Management, LLC ($93K) and Citadel Advisors ($85K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Estrella Immunopharma Inc.
- CUSIP
- 297584104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $85K |
| Exits | 1 | $13K |
All 13F filers, Q4 2024 → Q1 2025: 356,110 shares bought and 35,241 shares sold, net +320,869 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Vanguard Group Inc. | 0.00% | Add +1180.1% | 277,578 | $257K |
| Geode Capital Management, LLC | 0.00% | Add +7.2% | 100,173 | $93K |
| Citadel Advisors | 0.00% | New | 91,599 | $85K |
| UBS Group AG | 0.00% | Reduce -37.0% | 41,034 | $38K |
| Atw Spac Management LLC | 0.06% | No change | 40,000 | $37K |
| BlackRock, Inc. | 0.00% | Reduce -1.9% | 24,653 | $23K |
| State Street Corp. | 0.00% | No change | 22,352 | $21K |
| MASO CAPITAL PARTNERS Ltd | 0.01% | No change | 10,000 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +49.0% | 5,646 | $5K |
| Bank of America Corp. | 0.00% | Add +4.8% | 87 | $81 |
| JPMorgan Chase & Co. | 0.00% | Reduce -11.5% | 23 | $21 |
"% of holder's portfolio" is ESLA's weight in each manager's 13F, not the share of Estrella Immunopharma Inc. the manager owns.